Select Year 202120202017 Select Month JanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember August 2021 August 20, 2021 - Generic & biosimilar industry to focus on expanding reach through emerging and traditional modalities: Expert Like0 likes Share Download August 20, 2021 - IP Alliance, CSIR organize 1st Pharmaceutical Innovation Exchange Forum Like1 likes Share Download August 18, 2021 - ‘Regulators should align to formulate standards for the approval of generic and biosimilar medicines – Sudarshan Jain’ Like0 likes Share Download August 17, 2021 - COVID-19 and Beyond: Focusing on a Patient-centric Culture Like0 likes Share Download August 15, 2021 - Scripting independent India’s pharma industry journey from non-existent to a world leader Like0 likes Share Download August 6, 2021 - IGBA focusing to promote enabling regulatory environment for generic and biosimilar industry Like0 likes Share Download Please refer to the Resources Archives section for Position Articles before 2016
August 2021 August 20, 2021 - Generic & biosimilar industry to focus on expanding reach through emerging and traditional modalities: Expert Like0 likes Share Download August 20, 2021 - IP Alliance, CSIR organize 1st Pharmaceutical Innovation Exchange Forum Like1 likes Share Download August 18, 2021 - ‘Regulators should align to formulate standards for the approval of generic and biosimilar medicines – Sudarshan Jain’ Like0 likes Share Download August 17, 2021 - COVID-19 and Beyond: Focusing on a Patient-centric Culture Like0 likes Share Download August 15, 2021 - Scripting independent India’s pharma industry journey from non-existent to a world leader Like0 likes Share Download August 6, 2021 - IGBA focusing to promote enabling regulatory environment for generic and biosimilar industry Like0 likes Share Download
August 20, 2021 - Generic & biosimilar industry to focus on expanding reach through emerging and traditional modalities: Expert Like0 likes Share Download
August 20, 2021 - IP Alliance, CSIR organize 1st Pharmaceutical Innovation Exchange Forum Like1 likes Share Download
August 18, 2021 - ‘Regulators should align to formulate standards for the approval of generic and biosimilar medicines – Sudarshan Jain’ Like0 likes Share Download
August 17, 2021 - COVID-19 and Beyond: Focusing on a Patient-centric Culture Like0 likes Share Download
August 15, 2021 - Scripting independent India’s pharma industry journey from non-existent to a world leader Like0 likes Share Download
August 6, 2021 - IGBA focusing to promote enabling regulatory environment for generic and biosimilar industry Like0 likes Share Download
